|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 31 August 2021, 17:29. The announcement is marked as price sensitive, and is 41 page(s) in length and 3.64MB in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.005% short sold according to ASIC data. It was ranked the 597th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Preliminary Final Report | 31 August 2021, 17:29 |
| August Investor Update | 17 August 2021, 8:45 |
| Ophthalmology-Focused Clinical Advisory Board | 17 August 2021, 8:43 |
| PYC Quarterly Investor Call - August 17 | 11 August 2021, 8:56 |
You must be logged in to post a reply.
